- 2020.5.26
- Patents, Articles & Conferences Patent “DNA aptamer capable of bonding to VWF” is granted in Japan.
- 2020.5.5
- News Release TAGCyx raises approximately 200 million JPY
- 2020.2.19
- News Release TAGCyx and GC Pharma has entered into collaborative research and development for conducting various pre-clinical studies of TAGX-0004
- 2019.12.25
- News Release TAGCyx receives milestone payment for collaborative research with HEALIOS K.K.
- 2019.10.10
- News Release TAGCyx enters into a collaborative aptamer glycosylation research agreement with GlyTech, Inc.
- 2019.10.9
- News Release TAGCyx has executed a collaborative antibody-aptamer conjugate research agreement with Chiome Bioscience Inc.
- 2019.9.19
- Event Aptamer Seminar in Tokyo will be held
- 2018.10.4
- Patents, Articles & Conferences Collaborator, Dr. Kazuya Sakai will present data of anti-von Willerbrand Factor A1 domain Xenoligo at the American Society of Hematology
- 2018.10.4
- Event TAGCyx will be presenting at Japan Healthcare Venture Summit 2018 at Yokohama
- 2018.9.28
- Patents, Articles & Conferences Dr. Kazuya Sakai will present data of our anti-coagulant aptamer at the 80th Annual Meeting of the Japanese Society of Hematology on Oct 13th 2018
- 2018.9.28
- News Release TAGCyx has executed collaborative research agreement with HEALIOS K.K.
- 2018.4.29
- News Release Completion of 500 million JPY Series B financing